Pharma-Bio Serv., a global compliance and validation services consulting solutions provider based in Dorado, announced net revenues for the three and six months ended April 30, 2013 of $8.3 and $15.9 million, an increase of approximately $1.2 and $2.5 million, or 17 percent and 18 percent, respectively, when compared to the same periods last year.
Bristol-Myers Squibb Company today broke ground on a $200 million expansion of its facility in Humacao to add manufacturing capacity that will prepare the plant for the production of additional medicines. The project is expected to create 100 full-time jobs at the facility over time.
Merck’s pharmaceutical operations in Puerto Rico are ramping up their production capacity with the recent addition of Liptruzet cholesterol inhibiting tablets, which are being manufactured in Las Piedras, Andrew Wirths, general manager of the company on the island, said Wednesday.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
